Stock RDHL REDHILL BIOPHARMA LTD.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features RedHill Biopharma Ltd.

Equities

RDHL

US7574682024

Delayed Nasdaq
Other stock markets
 12:52:10 2024-05-21 pm EDT 		5-day change 1st Jan Change
0.47 USD +2.17% Intraday chart for RedHill Biopharma Ltd. +2.82% -67.81%
May. 06 Redhill Biopharma Awarded China Patent for Investigational Ebola Drug Opaganib MT
May. 06 RedHill Biopharma Ltd. Announces New Opaganib Chinese Patent against Ebola Virus Valid Through 2035 CI

MarketScreener Editorial Features

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Today on Wall Street: US tech giants return to top spotToday on Wall Street: US tech giants return to top spot August 31, 2021 at 09:25 am EDT
Analyst recommendations: AT&T, BancorpSouth Bank, CMO Group, Magnite, Textron...ANALYST RECOMMENDATIONS : AT&T, BancorpSouth Bank, CMO Group, Magnite, Textron... August 31, 2021 at 06:47 am EDT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RDHL Stock
  4. News RedHill Biopharma Ltd.
  5. MarketScreener Editorial Features
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW